EMERALD BIOVENTURES, LLC enters GALERA THERAPEUTICS, INC. with 40.22M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/4/2026ACC: 0001123292-26-000595
10% Owner
Since Apr 2026
40.22M
Baseline shares
100% direct
40.22M
Direct ownership
1 position
20.81M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned40.22M
Total
40.22M direct40.22M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.22M | Direct |
| Total | 40.22M | 40.22M direct |
Derivative Holdings1
Series B Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
20.81M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
20.81M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock | — | — | 20.81M | N/A | |
| Total | 20.81M | 0.00 | ||||